Trial intelligence / Profile preview

Bioequivalence study of 20 mg memantine hydrochloride film-coated tablets in healthy Thai volunteers

TCTR20161103001Phase 4Completed

Sponsor
Research and Development
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Research and Development. Started Nov 2016; status: completed.

02

Drugs

memantine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on TCTR20161103001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20161103001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call